Home

Novartis India Ltd EPS

Image

Novartis India Ltd

NSE: NOVARTIND

EPS

₹ 40.87

Last updated on: May 12, 2025

Key Highlights

  • The Earning per Share of Novartis India Ltd is ₹ 40.87 as of 12 May 25 .
  • The earning per share of Novartis India Ltd changed from ₹ 8.21 to ₹ 11.87 over 8 quarters. This represents a CAGR of 20.24% .

Historical Earning per Share of Novartis India Ltd

No data available

* All values are in

Company Fundamentals for Novartis India Ltd

Market Cap

2,084 Cr

EPS

40.9

P/E Ratio (TTM)

20.7

P/B Ratio (TTM)

2.7

Day’s High

890.0

Day’s Low

815.0

DTE

0.0

ROE

12.9

52 Week High

1248.0

52 Week Low

744.95

ROCE

16.6

Market Price of Novartis India Ltd

1M

1Y

3Y

5Y

Monitoring Novartis India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 May 2025844.2
09 May 2025804.1
08 May 2025797.4
07 May 2025782.05
06 May 2025782.3
05 May 2025785.75
02 May 2025792
30 Apr 2025765.8
29 Apr 2025771.45
28 Apr 2025793.05

SWOT Analysis Of Novartis India Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Novartis India Ltd

Asset Value vs Market Value of Novartis India Ltd

Market Value

2,084

Asset Value

Value addition

1.9 X

723

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Novartis India Ltd2084
Sun Pharmaceutical Industries Ltd404588
Divis Laboratories Ltd157711
Cipla Ltd122115
Torrent Pharmaceuticals Ltd109584
Mankind Pharma Ltd103054

Historical Market Cap of Novartis India Ltd

No data available

* All values are in crore

Historical Revenue of Novartis India Ltd

No data available

* All values are in crore

Historical EBITDA of Novartis India Ltd

No data available

* All values are in crore

Historical Net Profit of Novartis India Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Novartis India Ltd News Hub

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October 2024. Powe

Read more

28 Sept 24

Novartis India standalone net profit declines 13.81% in the September 2024 quarter

Net profit of Novartis India declined 13.81% to Rs 20.41 crore in the quarter ended September 2024 a

Read more

25 Oct 24

Board of Novartis India recommends final dividend

Novartis India announced that the Board of Directors of the Company at its meeting held on 9 May 202

Read more

10 May 25

Novartis India to hold board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 28 January 2025. Powe

Read more

28 Dec 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Novartis India Ltd

What is the EPS of Novartis India Ltd stock?

The Earnings Per Share (EPS) of Novartis India Ltd is 40.87. An EPS is the amount of net income attributed to each share of a common stock.

How is Novartis India Ltd EPS calculated?

The EPS of Novartis India Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Novartis India Ltd report its EPS?

Novartis India Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Novartis India Ltd EPS?

Factors that influence the EPS of Novartis India Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Novartis India Ltd EPS growth indicate future performance?

Yes, consistent growth in Novartis India Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions